Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver–Derived Cells by Attenuating Splicing-Reference-Cited by-同舟云学术

Adenosine Deaminases Acting on RNA Downregulate the Expression of Constitutive Androstane Receptor in the Human Liver–Derived Cells by Attenuating Splicing

Published:2019-07-03 Issue:3 Volume:370 Page:408-415
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Nakano Masataka,Fukami Tatsuki,Nakajima Miki

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference36 articles.

1. A novel tissue-specific alternatively spliced form of the A-to-I RNA editing enzyme ADAR2

2. ADAR1 deletion induces NFκB and interferon signaling dependent liver inflammation and fibrosis;Ben-Shoshan;RNA Biol,2017

3. Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)

4. Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation

5. Structure and Sequence Determinants Required for the RNA Editing of ADAR2 Substrates

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Evaluation of the Effects of RNA-Editing Proteins ADAR and ADARB1 on the Expression of the Drug-Metabolizing Enzymes in HepaRG Cells;Drug Metabolism and Disposition;2023-08-02

2. Cascade-Responsive 2-DG Nanocapsules Encapsulate aV-siCPT1C Conjugates to Inhibit Glioblastoma through Multiple Inhibition of Energy Metabolism;ACS Applied Materials & Interfaces;2023-02-14

3. Adenosine-to-Inosine RNA Editing and N⁶-Methyladenosine Modification Modulating Expression of Drug Metabolizing Enzymes;Drug Metabolism and Disposition;2022-02-12

4. Adenosine deaminases acting on RNA modulate the expression of the human pregnane X receptor;Drug Metabolism and Pharmacokinetics;2021-04

5. Regulation of CAR and PXR Expression in Health and Disease;Cells;2020-10-31